🇺🇸 FDA
Patent

US 8088379

Modified T cell receptors and related materials and methods

granted A61KA61K38/00A61P

Quick answer

US patent 8088379 (Modified T cell receptors and related materials and methods) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K38/00, A61P, A61P31/00, A61P35/00